Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • CompBio
    Member
    • Aug 2009
    • 26

    #16
    Originally posted by kmcarr View Post
    The template DNA fragment is longer than the read length but since a only finite number of cycles are being performed it does not matter how long the template is.
    Thanks for responding so quickly. That was the piece I was missing. I had assumed that if you had 200-bp fragments, you'd want to sequence the whole thing.

    I've seen in the literature and in data files (e.g., NCBI's short read archive) that the base call error rate increases with read length--is that why runs are limited to 40 or 50 cycles?

    Comment

    • Anthony
      Junior Member
      • Feb 2009
      • 2

      #17
      Hi,
      The fragmentation range is from 60bp up to 3KB. The system is highly reproducible at selected fragmentation size. If you need any help please feel free to contact me [email protected] , plentyof papers around and support litereature. Thanks

      Originally posted by polivares View Post
      Hi,
      I would like to know the fragmentation size spectrum of the covaris s2. Some resources state that the minimum size is around 600 bp but others state that it is 60 bp. Besides, does reproducibility varies along fragment size?
      Thank you

      Comment

      • greigite
        Senior Member
        • Mar 2009
        • 145

        #18
        insert size and evenness

        I'm also curious what people's experience is using different library insert sizes. This paper recommends a 600 bp insert size to lessen over-representation of ends relative to 200 bp. Any comments on your observations of insert size/coverage evenness?

        Comment

        • jgibbons1
          Senior Member
          • Oct 2009
          • 135

          #19
          marklar...i was wondering if you could give me a ballpark estimate of the Bioruptor price.
          We're looking to get one of these machines as well.

          Thanks,
          John

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          34 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Working...